T. Rowe Price Investment Management, Inc. Cabaletta Bio, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,470,493 shares of CABA stock, worth $17.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,470,493
Previous 1,832,854
34.79%
Holding current value
$17.4 Million
Previous $41.6 Million
1.3%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding CABA
# of Institutions
168Shares Held
48.8MCall Options Held
300KPut Options Held
1.31M-
Black Rock Inc. New York, NY4.06MShares$28.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$26.4 Million0.0% of portfolio
-
Jennison Associates LLC3.42MShares$24.1 Million0.04% of portfolio
-
Fred Alger Management, LLC New York, NY3.11MShares$21.9 Million0.27% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$21.4 Million0.1% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $205M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...